Zessly 100 mg powder for concentrate for solution for infusion
- Licence status
- Active substances
- Infliximab
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/18/1280/001-005
- Licence holder
- Sandoz GmbH
Product documents
Licence information
- ATC code
- L04AB Tumor necrosis factor alpha (TNF-) inhibitors, L04AB02 infliximab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 18/05/2018